Process development for pandemic influenza VLP vaccine production using a baculovirus expression system

被引:35
作者
Lai, Chia-Chun [1 ,2 ]
Cheng, Yu-Chieh [1 ]
Chen, Pin-Wen [1 ]
Lin, Ting-Hui [1 ,2 ]
Tzeng, Tsai-Teng [1 ]
Lu, Chia-Chun [1 ]
Lee, Min-Shi [1 ]
Hu, Alan Yung-Chih [1 ]
机构
[1] NHRI, Natl Inst Infect Dis & Vaccinol, 35 Keyan Rd, Zhunan 35053, Miaoli County, Taiwan
[2] Natl Tsing Hua Univ, Coll Life Sci, 101,Sect 2,Kuang Fu Rd, Hsinchu 30013, Taiwan
关键词
Influenza vaccines; Virus-like particle; Dissolved oxygen; VIRUS-LIKE PARTICLES; PROTECTIVE IMMUNITY; H7N9; INFLUENZA; GENERATION;
D O I
10.1186/s13036-019-0206-z
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background Influenza viruses cause hundreds of thousands of respiratory diseases worldwide each year, and vaccination is considered the most effective approach for preventing influenza annual epidemics or pandemics. Since 1950, chicken embryonated eggs have been used as the main method for producing seasonal influenza vaccines. However, this platform has the main drawback of a lack of scale-up flexibility, and thus, egg-based vaccine manufacturers cannot supply sufficient doses within a short period for use for pandemic prevention. As a result, strategies for reducing the manufacturing time and increasing production capacity are urgently needed. Non-virion vaccine methods have been considered an alternative strategy against an influenza pandemic, and the purpose of maintaining an immunogenic capsule structure with infectious properties appears to be met by the virus-like particle (VLP) platform. Results An influenza H7N9-TW VLP production platform using insect cells, which included the expression of hemagglutinin (HA), NA, and M1 proteins, was established. To scale up H7N9-TW VLP production, several culture conditions were optimized to obtain a higher production yield. A high level of dissolved oxygen (DO) could be critical to H7N9-TW VLP production. If the DO was maintained at a high level, the HA titer obtained in the spinner flask system with ventilation was similar to that obtained in a shake flask. In this study, the HA titer in a 5-L bioreactor with a well-controlled DO level was substantially improved by 128-fold (from 4 HA units (HAU)/50 mu L to 512 HAU/50 mu L). Conclusions In this study, a multigene expression platform and an effective upstream process were developed. Notably, a high H7N9-TW VLP yield was achieved using a two-step production strategy while a high DO level was maintained. The upstream process, which resulted in high VLP titers, could be further used for large-scale influenza VLP vaccine production.
引用
收藏
页数:9
相关论文
共 44 条
[21]   Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development [J].
Kushnir, Natasha ;
Streatfield, Stephen J. ;
Yusibov, Vidadi .
VACCINE, 2012, 31 (01) :58-83
[22]   Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals [J].
Leang, Sook-Kwan ;
Hurt, Aeron C. .
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2017, (122)
[23]   Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine [J].
Li, Changgui ;
Xu, Kangwei ;
Hashem, Anwar ;
Shao, Ming ;
Liu, Shuzhen ;
Zou, Yong ;
Gao, Qiang ;
Zhang, Yongchao ;
Yuan, Liyong ;
Xu, Miao ;
Li, Xuguang ;
Wang, Junzhi .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (06) :1351-1356
[24]  
Li X, 2015, J VACCINES VACCIN, P6
[25]   Use of baculovirus expression system for generation of virus-like particles: Successes and challenges [J].
Liu, Fuxiao ;
Wu, Xiaodong ;
Li, Lin ;
Liu, Zengshan ;
Wang, Zhiliang .
PROTEIN EXPRESSION AND PURIFICATION, 2013, 90 (02) :104-116
[26]   Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets [J].
Liu, Ye V. ;
Massare, Michael J. ;
Pearce, Melissa B. ;
Sun, Xiangjie ;
Belser, Jessica A. ;
Maines, Taronna R. ;
Creager, Hannah M. ;
Glenn, Gregory M. ;
Pushko, Peter ;
Smith, Gale E. ;
Tumpey, Terrence M. .
VACCINE, 2015, 33 (18) :2152-2158
[27]   Improved Production Efficiency of Virus-Like Particles by the Baculovirus Expression Vector System [J].
Lopez-Vidal, Javier ;
Gomez-Sebastian, Silvia ;
Barcena, Juan ;
del Carmen Nunez, Maria ;
Martinez-Alonso, Diego ;
Dudognon, Benoit ;
Guijarro, Eva ;
Escribano, Jose M. .
PLOS ONE, 2015, 10 (10)
[28]  
LT Corporation, 2017, GROWTH MAINT INS CEL
[29]   Bioengineering Virus-Like Particles as Vaccines [J].
Lua, Linda H. L. ;
Connors, Natalie K. ;
Sainsbury, Frank ;
Chuan, Yap P. ;
Wibowo, Nani ;
Middelberg, Anton P. J. .
BIOTECHNOLOGY AND BIOENGINEERING, 2014, 111 (03) :425-440
[30]   Major findings and recent advances in virus like particle (VLP)-based vaccines [J].
Mohsen, Mona O. ;
Zha, Lisha ;
Cabral-Miranda, Gustavo ;
Bachmann, Martin F. .
SEMINARS IN IMMUNOLOGY, 2017, 34 (0C) :123-132